These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 8657340)

  • 21. Acute spinal cord injury: pharmacotherapy and drug development perspectives.
    Blight AR; Zimber MP
    Curr Opin Investig Drugs; 2001 Jun; 2(6):801-8. PubMed ID: 11572660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology, physiopathology, and experimental therapeutics of acute spinal cord injury.
    Albin MS; White RJ
    Crit Care Clin; 1987 Jul; 3(3):441-52. PubMed ID: 3332209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effects of edaravone on experimental spinal cord injury in rats.
    Ozgiray E; Serarslan Y; Oztürk OH; Altaş M; Aras M; Söğüt S; Yurtseven T; Oran I; Zileli M
    Pediatr Neurosurg; 2011; 47(4):254-60. PubMed ID: 22310070
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antioxidative therapy in contusion spinal cord injury.
    Cristante AF; Barros Filho TE; Oliveira RP; Marcon RM; Rocha ID; Hanania FR; Daci K
    Spinal Cord; 2009 Jun; 47(6):458-63. PubMed ID: 19065150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the behavioral and anatomical outcomes in sub-acute and chronic spinal cord injury models following treatment with human mesenchymal precursor cell transplantation and recombinant decorin.
    Hodgetts SI; Simmons PJ; Plant GW
    Exp Neurol; 2013 Oct; 248():343-59. PubMed ID: 23867131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urgent surgical decompression compared to methylprednisolone for the treatment of acute spinal cord injury: a randomized prospective study in beagle dogs.
    Rabinowitz RS; Eck JC; Harper CM; Larson DR; Jimenez MA; Parisi JE; Friedman JA; Yaszemski MJ; Currier BL
    Spine (Phila Pa 1976); 2008 Oct; 33(21):2260-8. PubMed ID: 18827690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kainate and metabolic perturbation mimicking spinal injury differentially contribute to early damage of locomotor networks in the in vitro neonatal rat spinal cord.
    Taccola G; Margaryan G; Mladinic M; Nistri A
    Neuroscience; 2008 Aug; 155(2):538-55. PubMed ID: 18602453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological management of spinal cord injury: current status of drugs designed to augment functional recovery of the injured human spinal cord.
    Greene KA; Marciano FF; Sonntag VK
    J Spinal Disord; 1996 Oct; 9(5):355-66. PubMed ID: 8938603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of spinal cord injury after repair of the thoracic or thoracoabdominal aorta.
    Mauney MC; Blackbourne LH; Langenburg SE; Buchanan SA; Kron IL; Tribble CG
    Ann Thorac Surg; 1995 Jan; 59(1):245-52. PubMed ID: 7818342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Time-level relationship for nitric oxide and the protective effects of aminoguanidine in experimental spinal cord injury.
    Soy O; Aslan O; Uzun H; Barut S; Iğdem AA; Belce A; Colak A
    Acta Neurochir (Wien); 2004 Dec; 146(12):1329-35; discussion 1335-6. PubMed ID: 15309585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ion channel blockers and spinal cord injury.
    Liu WM; Wu JY; Li FC; Chen QX
    J Neurosci Res; 2011 Jun; 89(6):791-801. PubMed ID: 21394757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain-derived neurotrophic factor stimulates hindlimb stepping and sprouting of cholinergic fibers after spinal cord injury.
    Jakeman LB; Wei P; Guan Z; Stokes BT
    Exp Neurol; 1998 Nov; 154(1):170-84. PubMed ID: 9875278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minocycline treatment inhibits lipid peroxidation, preserves spinal cord ultrastructure, and improves functional outcome after traumatic spinal cord injury in the rat.
    Sonmez E; Kabatas S; Ozen O; Karabay G; Turkoglu S; Ogus E; Yilmaz C; Caner H; Altinors N
    Spine (Phila Pa 1976); 2013 Jul; 38(15):1253-9. PubMed ID: 23370685
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antioxidant effects in brain and spinal cord injury.
    Hall ED; Braughler JM; McCall JM
    J Neurotrauma; 1992 Mar; 9 Suppl 1():S165-72. PubMed ID: 1588607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methylprednisolone after spinal cord injury.
    Segatore M; Way C
    SCI Nurs; 1993 Mar; 10(1):8-14. PubMed ID: 8484108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of lipid peroxidation in CNS injury.
    Braughler JM; Hall ED
    J Neurotrauma; 1992 Mar; 9 Suppl 1():S1-7. PubMed ID: 1588600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early metabolic reactivation versus antioxidant therapy after a traumatic spinal cord injury in adult rats.
    Torres S; Salgado-Ceballos H; Torres JL; Orozco-Suarez S; Díaz-Ruíz A; Martínez A; Rivera-Cruz M; Ríos C; Lara A; Collado C; Guizar-Sahagún G
    Neuropathology; 2010 Feb; 30(1):36-43. PubMed ID: 19563509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endorphins in experimental spinal injury: therapeutic effect of naloxone.
    Faden AI; Jacobs TP; Mougey E; Holaday JW
    Ann Neurol; 1981 Oct; 10(4):326-32. PubMed ID: 6274252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary injury mechanisms in acute spinal cord injury.
    Young W
    J Emerg Med; 1993; 11 Suppl 1():13-22. PubMed ID: 8445198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacotherapy in spinal cord injury: a critical review of recent developments.
    Faden AI
    Clin Neuropharmacol; 1987 Jun; 10(3):193-204. PubMed ID: 2842048
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.